| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.064 | 0.8 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |